
DR.NOAH BIOTECH’s AI-driven ALS Medicine Receives U.S. FDA Approval for Phase 1 Clinical Trial IND
Seoul, Korea – September 02, 2024 – (SeaPRwire) – DR.NOAH BIOTECH (hereafter DR.NOAH), an AI-driven innovative drug development company, announced on August 23 that it had received approval from the U.S. Food and Drug Administration (FDA) for the Investigational New Drug (IND) application for Phase 1 clinical trial of a new drug combination (NDC-011) for Amyotrophic... » read more